losartan and perindopril

losartan has been researched along with perindopril in 63 studies

Research

Studies (63)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's13 (20.63)18.2507
2000's35 (55.56)29.6817
2010's11 (17.46)24.3611
2020's4 (6.35)2.80

Authors

AuthorsStudies
Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Janiak, P; Pillon, A; Prost, JF; Vilaine, JP1
Bertram, JF; Black, MJ; Bobik, A; O'Sullivan, JB1
Janiak, P; Libert, O; Vilaine, JP1
Chauvin, B; Giudicelli, JF; Richer, C1
Anderson, NH; Bohr, DF; Devlin, AM; Dominiczak, AF; Lee, WK; Reid, JL1
Funder, JW; Young, MJ1
Black, MJ; Bobik, A; Kanellakis, P1
Cerutti, C; Ducher, M; Lantelme, P; Lo, M; Paultre, CZ1
Corradi, L; Fogari, R; Lazzari, P; Lusardi, P; Mugellini, A; Preti, P; Zoppi, A1
Anderson, NH; Devlin, AM; Dominiczak, AF; Graham, D; Hamilton, CA; Morton, JJ; Reid, JL; Schork, NJ1
Heller, J; Hellerová, S1
Mackay, FJ; Mann, RD; Pearce, GL1
Altun, B; Arici, M; Cağlar, S; Erdem, Y; Haznedaroğlu, IC; Turgan, C; Usalan, C; Yasavul, U1
Henrion, D; Lévy, BI; Matrougui, K1
Chiang, YF; Lee, YJ; Tsai, JC1
Duhault, J; Lonchampt, M; Pennel, L1
Chanudet, X; De Champvallins, M1
Egashira, K; Ito, A; Muramatsu, K; Narishige, T; Takeshita, A1
Delbridge, LM; Griffiths, CD; Morgan, TO1
Laurent, S1
Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A1
Schiffrin, EL1
Bertram, D; Blanc-Brunat, N; Lo, M; Sassard, J1
Gurevich, MA1
Li, YJ; Liao, DF; Qin, XP; Ye, F1
Horie, H; Horie, M; Kinoshita, M; Matsumoto, T; Matsuo, S; Minai, K; Ohira, N; Ozawa, T; Takashima, H; Tarutani, Y; Yasuda, Y1
Li, X; Meng, Y; Wu, PS; Yang, XS; Zhang, ZS1
Delbridge, LM; Morgan, TO; Trongtorsak, P1
Hayashi, K; Homma, K; Kanda, T; Matsuda, H; Saruta, T; Takamatsu, I; Tatematsu, S; Wakino, S; Yoshioka, K1
Aronow, WS; Frishman, WH1
Chan, JS; Fantus, IG; Filep, JG; Fustier, P; Hamet, P; Hsieh, TJ; Ingelfinger, JR; Tang, SS; Wei, CC; Zhang, SL1
Chapuis, B; Liu, KL; Lo, M; Naelten, G1
Shimabukuro, M; Tagawa, T; Ueda, S; Watanabe, S; Yamakawa, K1
Araki, N; Fujimura, A; Ioka, T; Sugimoto, K; Tsuruoka, S; Wakaumi, M1
Lo, M; Naelten, G; Trigo, LF1
Brezniceanu, ML; Chan, JS; Filep, JG; Guo, DF; Hamet, P; Hsieh, TJ; Ingelfinger, JR; Liu, F; Liu, Q; Sachetelli, S; Sigmund, CD; Zhang, SL1
Dai, Y; Lan, XB; Ling, ZY; Liu, ZC; Luo, KL; Su, L; Wu, JJ; Yang, XY; Yin, YH1
Dai, Y; Dalal, D; Dong, J; Lan, X; Ling, Z; Liu, D; Liu, Z; Luo, K; She, Q; Su, L; Woo, K; Wu, J; Yin, Y1
Li, G; Liu, T1
Gopalam, M; Kanna, B1
Ismail, SB; Naing, L; Rahman, AR; Rehman, A; Roshan, TM1
Chiara Cavallini, M; Palmieri, V; Pini, R1
Brezniceanu, ML; Chan, JS; Chénier, I; Filep, JG; Ingelfinger, JR; Liu, F; Sachetelli, S; Wei, CC; Zhang, SL1
Cochain, C; Duriez, M; Lévy, BI; Loinard, C; Mees, B; Silvestre, JS; Vilar, J; You, D1
Cai, SX; Cheng, YX; Li, X; Meng, Y; Tong, WC1
Mourad, JJ; Waeber, B1
Jia, M; Li, L; Liu, RY; Lu, PQ; Zhang, JY; Zhao, XY1
Chou, PC; Hsiao, PJ; Hsieh, TJ; Hung, WW; Lin, KD; Lin, T; Shin, SJ1
Al-Ismaeel, H; Al-Rikabi, AC; Al-Shabanah, OA; Mansour, MA1
Chan, JS; Chenier, I; Filep, JG; Godin, N; Ingelfinger, JR; Liu, F; Lo, CS; Maachi, H; Shi, Y; Zhang, SL1
Huang, S; Li, C; Li, X; Li, Y; Luo, W; Ni, S1
Barykina, IN; Chumachok, EV; Ledyaeva, AA; Mazina, G; Nedogoda, SV; Salasyuk, AS; Tsoma, VV1
Csajági, E; Major, Z; Pavlik, G; Szauder, I; Ujhelyi, G1
Al-Sharea, A; Dart, AM; Du, XJ; Gao, XM; Han, LP; Kiriazis, H; Moore, S; Murphy, AJ; Su, Y; Tsai, A1
Abdelghany, RH; El-Ahwany, E; Goda, R; Helal, NS; Mahmoud, AAA; Saber, S1
Bourke, JP; Bueser, T; Quinlivan, R1
Aiglova, R; Cernicek, V; Danek, J; Gloger, V; Lazarova, M; Pavlu, L; Precek, J; Schee, A; Skala, T; Taborsky, M; Vicha, M1
Tchernev, G1
Ardiana, M; Harsoyo, PM; Hermawan, HO; Muhammad, AR; Sufiyah, IM; Suryawan, IGR; Zaini, BSI1
Alaba, OA; Gumedze, F; Jones, ESW; Ntusi, NAB; Snyman, JR; Tsabedze, N; Vira, A1

Reviews

5 review(s) available for losartan and perindopril

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
    The Canadian journal of cardiology, 2002, Volume: 18 Suppl A

    Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteries; Atenolol; Biphenyl Compounds; Cilazapril; Humans; Hypertension; Irbesartan; Losartan; Perindopril; Tetrazoles

2002
[Policy of antihypertensive therapy in arterial hypertension in the elderly. II].
    Klinicheskaia meditsina, 2002, Volume: 80, Issue:9

    Topics: Acrylates; Adrenergic alpha-Antagonists; Age Factors; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Doxazosin; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Perindopril; Risk Factors; Sex Factors; Sodium Chloride Symporter Inhibitors; Thiophenes

2002
Treatment of hypertension and prevention of ischemic stroke.
    Current cardiology reports, 2004, Volume: 6, Issue:2

    Topics: Algorithms; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Diltiazem; Humans; Hypertension; Losartan; Perindopril; Stroke

2004
Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.
    The Cochrane database of systematic reviews, 2018, Oct-16, Volume: 10

    Topics: Adolescent; Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiovascular Agents; Child; Disease Progression; Eplerenone; Human Growth Hormone; Humans; Lisinopril; Losartan; Male; Muscular Dystrophy, Duchenne; Non-Randomized Controlled Trials as Topic; Perindopril; Placebos; Randomized Controlled Trials as Topic; Stroke Volume; Ubiquinone; Young Adult

2018

Trials

16 trial(s) available for losartan and perindopril

ArticleYear
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
    Journal of cardiovascular pharmacology, 1998, Volume: 32, Issue:4

    Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Hemodynamics; Humans; Hypertension; Indoles; Insulin Resistance; Losartan; Male; Middle Aged; Obesity; Perindopril

1998
Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension.
    American journal of hypertension, 1999, Volume: 12, Issue:11 Pt 1

    Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Female; Fibrinolysis; Fibrinolytic Agents; Humans; Hypertension; Lipoproteins; Losartan; Male; Middle Aged; Perindopril; Plasminogen Activator Inhibitor 1; Thrombomodulin; Tissue Plasminogen Activator

1999
Severe nonproductive cough and cough-induced stress urinary incontinence in diabetic postmenopausal women treated with ACE inhibitor.
    Diabetes care, 2000, Volume: 23, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Cough; Diabetic Angiopathies; Double-Blind Method; Female; Humans; Hypertension; Losartan; Perindopril; Postmenopause; Prevalence; Prospective Studies; Urinary Incontinence, Stress

2000
Antihypertensive efficacy and tolerability of low-dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension.
    International journal of clinical practice, 2001, Volume: 55, Issue:4

    Topics: Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Indapamide; Losartan; Male; Middle Aged; Perindopril; Prospective Studies; Treatment Outcome

2001
Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension.
    Japanese circulation journal, 2001, Volume: 65, Issue:9

    Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Bisoprolol; Blood Pressure; Endothelium, Vascular; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Nitric Oxide Synthase; Perindopril; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; von Willebrand Factor

2001
Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 2001, Volume: 19, Issue:4

    Topics: Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Humans; Hypertension; Indapamide; Losartan; Perindopril; Safety; Time Factors

2001
Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients.
    American journal of hypertension, 2002, Volume: 15, Issue:4 Pt 1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertension; Losartan; Male; Middle Aged; Perindopril; Plasminogen Activator Inhibitor 1

2002
Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients.
    Journal of the American College of Cardiology, 2003, Apr-16, Volume: 41, Issue:8

    Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bradykinin; Coronary Circulation; Dose-Response Relationship, Drug; Female; Fibrinolysis; Humans; Hypertension; Losartan; Male; Middle Aged; Perindopril; Receptor, Angiotensin, Type 1; Tissue Plasminogen Activator

2003
Differing anti-proteinuric action of candesartan and losartan in chronic renal disease.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2003, Volume: 26, Issue:11

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Female; Humans; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Nitric Oxide; Perindopril; Proteinuria; Tetrazoles

2003
Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans.
    Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:11

    Topics: Acetylcholine; Adult; Anticoagulants; Antihypertensive Agents; Endothelium, Vascular; Enzyme Inhibitors; Fatty Acids, Nonesterified; Heparin; Humans; Lipids; Losartan; Male; omega-N-Methylarginine; Perindopril; Plethysmography; Regional Blood Flow; Renin-Angiotensin System; Vasodilation; Vasodilator Agents

2005
Comparative study of taste disturbance by losartan and perindopril in healthy volunteers.
    Journal of clinical pharmacology, 2005, Volume: 45, Issue:11

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Asian People; Cross-Over Studies; Double-Blind Method; Humans; Losartan; Male; Middle Aged; Perindopril; Renin; Saliva; Taste Threshold; Zinc

2005
[Long-term clinical efficacy of losartan or perindopril combination therapy with low-dose amiodarone in patients with paroxysmal atrial fibrillation].
    Zhonghua xin xue guan bing za zhi, 2006, Volume: 34, Issue:4

    Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Losartan; Male; Middle Aged; Perindopril; Prospective Studies

2006
Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation.
    European heart journal, 2006, Volume: 27, Issue:15

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Drug Therapy, Combination; Female; Heart Atria; Humans; Losartan; Male; Middle Aged; Perindopril; Prospective Studies; Secondary Prevention; Treatment Outcome

2006
Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A comparative study among malay hypertensive subjects with a known genetic profile.
    American journal of hypertension, 2007, Volume: 20, Issue:2

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aorta; Double-Blind Method; Female; Humans; Hypertension; Losartan; Malaysia; Male; Perindopril; Polymorphism, Genetic; Pulse; Receptor, Angiotensin, Type 1

2007
Randomized trial of perindopril, enalapril, losartan and telmisartan in overweight or obese patients with hypertension.
    Clinical drug investigation, 2013, Volume: 33, Issue:8

    Topics: Adult; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Obesity; Overweight; Perindopril; Single-Blind Method; Telmisartan

2013
Treatment of Hypertension: Favourable Effect of the Twice-Daily Compared to the Once-Daily (Evening) Administration of Perindopril and Losartan.
    Kidney & blood pressure research, 2015, Volume: 40, Issue:4

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Drug Administration Schedule; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Perindopril

2015

Other Studies

42 other study(ies) available for losartan and perindopril

ArticleYear
Interaction of digoxin with antihypertensive drugs via MDR1.
    Life sciences, 2002, Feb-15, Volume: 70, Issue:13

    Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors

2002
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Role of angiotensin subtype 2 receptor in neointima formation after vascular injury.
    Hypertension (Dallas, Tex. : 1979), 1992, Volume: 20, Issue:6

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Carotid Arteries; Carotid Artery Injuries; Catheterization; Hyperplasia; Imidazoles; Indoles; Losartan; Male; Oligopeptides; Perindopril; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles; Tunica Intima

1992
Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    Journal of hypertension, 1994, Volume: 12, Issue:10

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Biphenyl Compounds; Blood Pressure; Body Weight; Cardiomegaly; Hypertension, Renovascular; Hypertrophy; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred WKY; Tetrazoles

1994
Role of the renin-angiotensin system in neointima formation after injury in rabbits.
    Hypertension (Dallas, Tex. : 1979), 1994, Volume: 24, Issue:6

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Bradykinin; Heart Rate; Imidazoles; Indoles; Losartan; Male; Oligopeptides; Perindopril; Rabbits; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Tunica Intima; Wound Healing

1994
Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.
    British journal of pharmacology, 1995, Volume: 116, Issue:4

    Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Decerebrate State; Hemodynamics; Hypertension; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred SHR; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles; Vasoconstriction

1995
Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
    Hypertension (Dallas, Tex. : 1979), 1996, Volume: 27, Issue:3 Pt 2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cardiomegaly; Female; Hypertension; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Polyploidy; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles

1996
The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis.
    The American journal of physiology, 1996, Volume: 271, Issue:5 Pt 1

    Topics: Aldosterone; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Canrenoic Acid; Cardiomegaly; Collagen; Corticosterone; Epithelium; Fibrosis; Heart; Imidazoles; Indoles; Losartan; Male; Myocardium; Nephrectomy; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renin-Angiotensin System; Tetrazoles

1996
Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
    Journal of hypertension, 1997, Volume: 15, Issue:9

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Body Weight; Cardiomegaly; Cardiovascular System; Hypertension; Hypertrophy; Indoles; Kidney; Losartan; Male; Mesenteric Arteries; Organ Size; Papaverine; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Vascular Resistance

1997
Mechanisms of spontaneous baroreflex impairment in lyon hypertensive rats.
    The American journal of physiology, 1998, Volume: 275, Issue:3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Heart Rate; Hypertension; Indoles; Losartan; Male; Perindopril; Rats

1998
Telemetry for cardiovascular monitoring in a pharmacological study: new approaches to data analysis.
    Hypertension (Dallas, Tex. : 1979), 1999, Volume: 33, Issue:1 Pt 2

    Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiomegaly; Cell Nucleus; Diastole; DNA; Female; Heart Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Indoles; Losartan; Lymphocytes; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Perindopril; Rats; Rats, Inbred SHR; Systole; Telemetry; Time Factors

1999
Long-term effect on blood pressure of early brief treatment by different antihypertensive agents: a study in the prague hypertensive rat.
    Kidney & blood pressure research, 1998, Volume: 21, Issue:6

    Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Genetic Predisposition to Disease; Hypertension; Indoles; Losartan; Male; Perindopril; Rats; Rats, Inbred Strains; Time Factors

1998
Cough and angiotensin II receptor antagonists: cause or confounding?
    British journal of clinical pharmacology, 1999, Volume: 47, Issue:1

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cohort Studies; Confounding Factors, Epidemiologic; Cough; Data Collection; Drug Monitoring; Enalapril; Female; Humans; Indoles; Lisinopril; Losartan; Male; Middle Aged; Perindopril

1999
Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats.
    British journal of pharmacology, 2000, Volume: 130, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Viscosity; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Imidazoles; Losartan; Mesenteric Arteries; Muscle Tonus; Perindopril; Phenylpropionates; Pyridines; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Splanchnic Circulation; Vascular Resistance; Vasodilation

2000
Hyperoxia/normoxia-driven retinal angiogenesis in mice: a role for angiotensin II.
    Investigative ophthalmology & visual science, 2001, Volume: 42, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Cell Count; Dextrans; Endothelium; Fluoresceins; Humans; Hyperoxia; Hypoxia; Imidazoles; Infant, Newborn; Losartan; Mice; Mice, Inbred C57BL; Perindopril; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Retinal Ganglion Cells; Retinal Neovascularization; Retinopathy of Prematurity

2001
Effects of combined administration of ACE inhibitor and angiotensin II receptor antagonist are prevented by a high NaCl intake.
    Journal of hypertension, 2001, Volume: 19, Issue:11

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Behavior, Animal; Blood; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Drug Synergism; Eating; Heart; Losartan; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Renin-Angiotensin System

2001
Differential evolution of blood pressure and renal lesions after RAS blockade in Lyon hypertensive rats.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2002, Volume: 283, Issue:5

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diuresis; Glomerulosclerosis, Focal Segmental; Hypertension, Renal; Kidney; Kidney Diseases; Losartan; Male; Natriuresis; Perindopril; Proteinuria; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System

2002
Involvement of calcitonin gene-related peptide in the depressor effects of losartan and perindopril in rats.
    European journal of pharmacology, 2003, Mar-07, Volume: 464, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcitonin Gene-Related Peptide; Gene Expression; Hypertension, Renovascular; Losartan; Male; Perindopril; Rats; Rats, Sprague-Dawley; RNA, Messenger

2003
[Effect of ACE-I and AT-1 receptor blocker on the progression of CCl(4)-inducing rat hepatic fibrogenesis].
    Zhonghua yi xue za zhi, 2003, Jul-25, Volume: 83, Issue:14

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Carbon Tetrachloride Poisoning; Hyaluronic Acid; Laminin; Liver Cirrhosis, Experimental; Losartan; Male; Matrix Metalloproteinase 2; Perindopril; Rats; Rats, Wistar

2003
Combined renin-angiotensin system blockade and dietary sodium restriction impairs cardiomyocyte contractility.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2003, Volume: 4, Issue:4

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Body Weight; Dose-Response Relationship, Drug; Heart; Losartan; Male; Myocardial Contraction; Myocytes, Cardiac; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sodium, Dietary

2003
Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells.
    The Journal of endocrinology, 2004, Volume: 183, Issue:3

    Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Azaserine; Cell Line; Gene Expression Regulation; Glucose; Imidazoles; Indicators and Reagents; Indoles; Insulin; Kidney Tubules, Proximal; Losartan; Maleimides; Perindopril; Protein Kinase C; Pyridines; Rats; Reactive Oxygen Species; Renin

2004
Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
    American journal of hypertension, 2005, Volume: 18, Issue:5 Pt 1

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Drug Therapy, Combination; Hypertension; Kidney; Losartan; Male; Perindopril; Rats; Renin-Angiotensin System

2005
Blood pressure and proteinuria after cessation of a brief renin-angiotensin system blockade in young and adult Lyon hypertensive rats.
    Journal of cardiovascular pharmacology, 2005, Volume: 46, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Losartan; Male; Perindopril; Proteinuria; Rats; Renin-Angiotensin System; Time Factors

2005
RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney.
    Kidney international, 2006, Volume: 69, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Blotting, Western; DNA, Complementary; Female; Gene Expression Regulation; Hypertension; Immunohistochemistry; Kidney; Kidney Diseases; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Perindopril; Proteins; Proteinuria; Rats; Renin-Angiotensin System

2006
Anti-inflammatory effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Potential benefits for the prevention of atrial fibrillation.
    European heart journal, 2006, Volume: 27, Issue:19

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Combinations; Humans; Losartan; Perindopril; Randomized Controlled Trials as Topic

2006
Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation.
    European heart journal, 2007, Volume: 28, Issue:3

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Humans; Losartan; Perindopril; Prospective Studies; Randomized Controlled Trials as Topic; Secondary Prevention

2007
Pulsology reloaded: commentary on similar effects of treatment on central and brachial blood pressure in older hypertensive subjects.
    Hypertension (Dallas, Tex. : 1979), 2007, Volume: 49, Issue:6

    Topics: Aged; Aged, 80 and over; Aging; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Losartan; Manometry; Perindopril; Ultrasonography, Doppler

2007
Overexpression of angiotensinogen increases tubular apoptosis in diabetes.
    Journal of the American Society of Nephrology : JASN, 2008, Volume: 19, Issue:2

    Topics: Albuminuria; Angiotensinogen; Animals; Antihypertensive Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Blood Glucose; Cell Line, Transformed; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hydralazine; Hypertension, Renal; Hypoglycemic Agents; Insulin; Kidney Tubules, Proximal; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Perindopril; Rats; Renin-Angiotensin System

2008
Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:6

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Bone Marrow Cells; Cell Differentiation; Disease Models, Animal; Endothelium, Vascular; Hindlimb; Hydralazine; Hypertension; Ischemia; Ligation; Losartan; Male; Neovascularization, Physiologic; Oxidative Stress; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stem Cells

2008
[Perindopril and losartan attenuate bleomycin A5-induced pulmonary fibrosis in rats].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2008, Volume: 28, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Bleomycin; Blotting, Western; Losartan; Male; NF-kappa B; Perindopril; Pulmonary Fibrosis; Random Allocation; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Transforming Growth Factor beta1

2008
Application in the STRATHE trial of a score system to compare the efficacy and the tolerability of different therapeutic strategies in the management of hypertension.
    Vascular health and risk management, 2008, Volume: 4, Issue:1

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Double-Blind Method; Drug Therapy, Combination; France; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Losartan; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Valine; Valsartan

2008
Effects of combination therapy with perindopril and losartan on left ventricular remodelling in patients with myocardial infarction.
    Clinical and experimental pharmacology & physiology, 2009, Volume: 36, Issue:7

    Topics: Aged; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Perindopril; Prospective Studies; Treatment Outcome; Ultrasonography; Ventricular Remodeling

2009
Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes.
    Cardiovascular drugs and therapy, 2011, Volume: 25, Issue:1

    Topics: 3T3-L1 Cells; Adipocytes; Adipokines; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Apelin; Captopril; Cells, Cultured; Imidazoles; Intercellular Signaling Peptides and Proteins; Lipid Metabolism; Losartan; Mice; Perindopril; Pyridines; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; RNA, Messenger

2011
Comparison of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade for the prevention of premalignant changes in the liver.
    Life sciences, 2011, Aug-01, Volume: 89, Issue:5-6

    Topics: alpha-Fetoproteins; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticarcinogenic Agents; Captopril; Carcinoembryonic Antigen; Endostatins; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factors; Hydroxyproline; Liver; Liver Neoplasms, Experimental; Losartan; Male; Matrix Metalloproteinase 2; Metallothionein; Perindopril; Precancerous Conditions; Rats; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A

2011
Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.
    American journal of physiology. Renal physiology, 2012, Apr-01, Volume: 302, Issue:7

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression; Hypertension; Kidney; Kidney Tubules, Proximal; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nephrosclerosis; Peptidyl-Dipeptidase A; Perindopril; Rats; Renin-Angiotensin System; Transgenes

2012
[Perindopril and losartan attenuate intrahepatic Toll-like receptor 4 protein expression in rats with bile duct ligation-induced hepatic fibrosis].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2012, Volume: 32, Issue:2

    Topics: Animals; Bile Ducts; Down-Regulation; Ligation; Liver Cirrhosis, Experimental; Losartan; Male; Perindopril; Rats; Rats, Wistar; Toll-Like Receptor 4

2012
Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture.
    Cardiovascular drugs and therapy, 2017, Volume: 31, Issue:2

    Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chemotaxis, Leukocyte; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rupture, Post-Infarction; Inflammation; Inflammation Mediators; Losartan; Male; Mice, 129 Strain; Monocytes; Myocardial Infarction; Myocardium; Neutrophil Infiltration; Neutrophils; Perindopril; Renin-Angiotensin System; Spleen; Time Factors

2017
Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B.
    Toxicology letters, 2018, Oct-01, Volume: 295

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cyclin D1; Diethylnitrosamine; Fosinopril; Liver Neoplasms, Experimental; Losartan; Male; Matrix Metalloproteinase 2; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; Niacinamide; Perindopril; Phenylurea Compounds; Phosphorylation; Renin-Angiotensin System; Signal Transduction; Sorafenib; Time Factors; Transcription Factor RelA; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2018
Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic.
    Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2022, Volume: 166, Issue:3

    Topics: Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Antihypertensive Agents; Czech Republic; Heart Failure; Humans; Losartan; Neprilysin; Perindopril; Ramipril; Retrospective Studies; Telmisartan; Valsartan

2022
NITROSOGENESIS OF SKIN CANCER: THE NITROSAMINE CONTAMINATION IN THE CALCIUM CHANNEL BLOCKERS (AMLODIPINE), BETA BLOCKERS (BISOPROLOL), SARTANS (VALSARTAN/LOSARTAN), ACE INHIBITORS (PERINDOPRIL/ENALAPRIL), TRICYCLIC ANTIDEPRESSANTS (MELITRACEN), SSRIS (PAR
    Georgian medical news, 2023, Issue:339

    Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antidepressive Agents, Tricyclic; Bisoprolol; Calcium Channel Blockers; Enalapril; Humans; Incidence; Losartan; Metformin; Paroxetine; Perindopril; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Skin Neoplasms; Valsartan; Venlafaxine Hydrochloride

2023
Perindopril and losartan attenuate pro-coagulation factors in human adipocytes exposed to SARS-CoV-2 spike protein.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2023, Volume: 74, Issue:3

    Topics: Adipocytes; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Blood Coagulation Factors; Cardiovascular Agents; COVID-19; Humans; Losartan; Male; Obesity; Perindopril; Plasminogen Activator Inhibitor 1; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Thromboplastin

2023
Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis.
    Advances in therapy, 2023, Volume: 40, Issue:11

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Enalapril; Humans; Hypertension; Losartan; Perindopril; South Africa

2023